Oxygen supplementation and cognitive function in long-COVID
Christine Gagnon(Montreal Heart Institute), Jean‐Claude Tardif(Montreal Heart Institute), Marie‐Claude Guertin, André Denault(Montreal Heart Institute), Thomas Vincent(Montreal Heart Institute), Mathieu Gayda(Montreal Heart Institute), Simon-Olivier Cloutier(Montreal Heart Institute), Isabelle Cloutier(Montreal Heart Institute), Stanislav Glezer(Health Outcomes Solutions (United States)), Louis Bherer(Montreal Heart Institute), Anna Nozza
Cited by 1
Related Papers
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k